<DOC>
	<DOC>NCT00548119</DOC>
	<brief_summary>The objective of this study is to gather additional information regarding the performance of NeoCart to fill articular cartilage defects in the knee.</brief_summary>
	<brief_title>NeoCart Phase 2 Clinical Trial</brief_title>
	<detailed_description />
	<criteria>Patients presenting with symptomatic knee pain indicative of an articular cartilage injury and able and willing to give informed consent. Patients with any previous surgical treatment other than debridement or microfracture of the study cartilage defect.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>